Theragent News and Resources

Theragent Inc., a contract development and manufacturing organisation (CDMO) for cell-based therapies, announced it has successfully produced the first batch of autologous cancer vaccine for CellVax Therapeutics Inc. This vaccine will be used to dose the initial patient in CellVax’s